Bristol Myers Squibb (BMY) Accounts Payables (2009 - 2026)
Bristol Myers Squibb's Accounts Payables was $4.16 billion in Q2 2026, down 23.4% from $5.43 billion a year earlier and down 1.8% from the prior quarter.
Bristol Myers Squibb (BMY) Accounts Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Bristol Myers Squibb came in at $3.58 billion, down 0.7% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of 5.7% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $3.6 billion in FY2024 (+10.5%), $3.26 billion in FY2023 (+7.2%), $3.04 billion in FY2022 (+3.1%) and $2.95 billion in FY2021 (+8.7%).
- Quarterly Accounts Payables has moved between $2.6 billion (Q3 2022) and $5.43 billion (Q2 2025) over five years.
- Compared with a year earlier, Accounts Payables was higher in six of the last eight quarters, with growth averaging 12.1%.
- The best year-over-year quarter for Accounts Payables over five years was Q2 2025 (growth of 44.7%); the worst was Q2 2026 (a decline of 23.4%).
- Per Business Quant data, BMY's Accounts Payables in the three quarters before Q2 2026 was $4.23 billion (Q1 2026), $3.58 billion (Q4 2025) and $4.29 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.45 Bn | 1,115.03 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 622.49 Bn | 541.02 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 509.47 Bn | 482.58 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 365.43 Bn | 319.80 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 297.34 Bn | 261.33 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.32 Bn | 235.01 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.29 Bn | 190.69 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 193.80 Bn | 167.99 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 171.68 Bn | 118.33 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Bristol Myers Squibb | 125.52 Bn | 76.79 Bn | 9.25 Bn | 4.16 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.16 Bn |
| Mar 31, 2026 | 4.23 Bn |
| Dec 31, 2025 | 3.58 Bn |
| Sep 30, 2025 | 4.29 Bn |
| Jun 30, 2025 | 5.43 Bn |
| Mar 31, 2025 | 4.00 Bn |
| Dec 31, 2024 | 3.60 Bn |
| Sep 30, 2024 | 3.47 Bn |
| Jun 30, 2024 | 3.75 Bn |
| Mar 31, 2024 | 3.54 Bn |
| Dec 31, 2023 | 3.26 Bn |
| Sep 30, 2023 | 2.81 Bn |
| Jun 30, 2023 | 3.07 Bn |
| Mar 31, 2023 | 3.19 Bn |
| Dec 31, 2022 | 3.04 Bn |
| Sep 30, 2022 | 2.60 Bn |
| Jun 30, 2022 | 2.88 Bn |
| Mar 31, 2022 | 2.94 Bn |
| Dec 31, 2021 | 2.95 Bn |
| Sep 30, 2021 | 2.70 Bn |
Bristol Myers Squibb Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();